They were actually issued at 20 cents to start with at the takeover and compared to the original drug company they are doing very well, so keep ramping down Gooseman, they are a speculative stock. I have confidence they will succeed, they are in the right market for future growth and hopefully 2018 will show a profit.
launches additions agent listings ? what a joke of a company, page-8
Add to My Watchlist
What is My Watchlist?
